This Article Full Text Full Text (PDF) Supplemental material Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, G. Articles by Ochi, K. Search for Related Content PubMed PubMed Citation Articles by Wang, G. Articles by Ochi, K. Agricola Articles by Wang, G. Articles by Ochi, K.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, May 2008, p. 2834-2840, Vol. 74, No. 9
0099-2240/08/$08.00+0     doi:10.1128/AEM.02800-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Dramatic Activation of Antibiotic Production in Streptomyces coelicolor by Cumulative Drug Resistance Mutations ^,

Guojun Wang, Takeshi Hosaka, and Kozo Ochi^*

National Food Research Institute, Tsukuba, Ibaraki 305-8642, Japan

Received 11 December 2007/ Accepted 23 February 2008

We recently described a new method to activate antibiotic production in bacteria by introducing a mutation conferring resistance to a drug such as streptomycin, rifampin, paromomycin, or gentamicin. This method, however, enhanced antibiotic production by only up to an order of magnitude. Working with Streptomyces coelicolor A3(2), we established a method for the dramatic activation of antibiotic production by the sequential introduction of multiple drug resistance mutations. Septuple and octuple mutants, C7 and C8, thus obtained by screening for resistance to seven or eight drugs, produced huge amounts (1.63 g/liter) of the polyketide antibiotic actinorhodin, 180-fold higher than the level produced by the wild type. This dramatic overproduction was due to the acquisition of mutant ribosomes, with aberrant protein and ppGpp synthesis activity, as demonstrated by in vitro protein synthesis assays and by the abolition of antibiotic overproduction with relA disruption. This new approach, called "ribosome engineering," requires less time, cost, and labor than other methods and may be widely utilized for bacterial strain improvement.

---

* Corresponding author. Mailing address: National Food Research Institute, 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8642, Japan. Phone: 81-29-838-8125. Fax: 81-29-838-7996. E-mail: kochi{at}affrc.go.jp

Published ahead of print on 29 February 2008.

Supplemental material for this article may be found at http://aem.asm.org/.

---

Applied and Environmental Microbiology, May 2008, p. 2834-2840, Vol. 74, No. 9
0099-2240/08/$08.00+0     doi:10.1128/AEM.02800-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Tanaka, Y., Komatsu, M., Okamoto, S., Tokuyama, S., Kaji, A., Ikeda, H., Ochi, K. (2009). Antibiotic Overproduction by rpsL and rsmG Mutants of Various Actinomycetes. Appl. Environ. Microbiol. 75: 4919-4922 [Abstract] [Full Text]  
• Kim, J.-Y., Inaoka, T., Hirooka, K., Matsuoka, H., Murata, M., Ohki, R., Adachi, Y., Fujita, Y., Ochi, K. (2009). Identification and Characterization of a Novel Multidrug Resistance Operon, mdtRP (yusOP), of Bacillus subtilis. J. Bacteriol. 191: 3273-3281 [Abstract] [Full Text]  
• Wang, G., Inaoka, T., Okamoto, S., Ochi, K. (2009). A Novel Insertion Mutation in Streptomyces coelicolor Ribosomal S12 Protein Results in Paromomycin Resistance and Antibiotic Overproduction. Antimicrob. Agents Chemother. 53: 1019-1026 [Abstract] [Full Text]  
• Tala, A., Wang, G., Zemanova, M., Okamoto, S., Ochi, K., Alifano, P. (2009). Activation of Dormant Bacterial Genes by Nonomuraea sp. Strain ATCC 39727 Mutant-Type RNA Polymerase. J. Bacteriol. 191: 805-814 [Abstract] [Full Text]